733
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Novel GO-COO-β-CD/CA inclusion: its blood compatibility, antibacterial property and drug delivery

, , , , &
Pages 362-369 | Accepted 18 Sep 2013, Published online: 28 Oct 2013

References

  • Acar A, Uygur F, Diktas H, et al. (2011). Comparison of silver-coated dressing (Acticoat (R)), chlorhexidine acetate 0.5% (Bactigrass (R)) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds. Burns 37:882–5
  • Agarwal A, Nelson TB, Kierski PR, et al. (2012). Polymeric multilayers that localize the release of chlorhexidine from biologic wound dressings. Biomaterials 33:6783–92
  • Baek JS, Cho CW. (2013). 2-Hydroxypropyl-beta-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells. J Pharm Pharmacol 65:72–8
  • Chaturvedi K, Ganguly K, Kulkarni AR, et al. (2011). Cyclodextrin-based siRNA<AQ1/> delivery nanocarriers: a state-of-the-art review. Expert Opin Drug Del 28:1455–68
  • Chowdhury SM, Lalwani G, Zhang KV, et al. (2013). Cell specific cytotoxicity and uptake of graphene nanoribbons. Biomaterials 34:283–93
  • Dembereldorj U, Kim M, Kim S, et al. (2012). A spatiotemporal anticancer drug release platform of Pegylated graphene oxide triggered by glutathione in vitro and in vivo. J Mater Chem 22:23845–51
  • Ferraz CCR, Gomes B, Zaia AA, et al. (2001). In vitro assessment of the antimicrobial action and the mechanical ability of chlorhexidine gel as an endodontic irrigant. J Endodont 27:452–5
  • Geim AK. (2009). Graphene: status and prospects. Science 324:1530–34
  • Katsnelson MI, Novoselov KS. (2007). Graphene: new bridge between condensed matter physics and quantum electrodynamics. Solid State Commun 143:3–13
  • Kuila T, Bose S, Khanra P, et al. (2011). Recent advances in graphene-based biosensors. Biosens Bioelectron 26:4637–48
  • Liu Z, Robinson JT, Sun X, et al. (2008). Pegylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc 130:10876–7
  • Lu F, Zhang SH, Gao HJ, et al. (2012). Protein-decorated reduced oxide graphene composite and its application to SERS. Acs Appl Mater Inter 4:3278–84
  • Meng N, Zhou NL, Zhang SQ, et al. (2009). Controlled release and antibacterial activity chlorohexidine acetate (CA) intercalated in montmorillonite. Int J Pharmaceut 382:45–9
  • Moya-Ortega MD, Alvarez-Lorenzo C, Concheiro A, et al. (2012). Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int J Pharmaceut 428:152–63
  • Murayama N, Terada Y, Okuaki M, et al. (2011). Dose assessment of 2% chlorohexidine acetate for canine superficial pyoderma. Vet Dermatol 22:449–53
  • Novoselov KS, Geim AK, Morozov SV, et al. (2005). Two-dimensional gas of massless Dirac fermions in graphene. Nature 438:197–200
  • Pei H, Li J, Lv M, et al. (2012). A graphene-based sensor array for high-precision and adaptive target identification with ensemble aptamers. J Am Chem Soc 134:13843–9
  • Shen AJ, Li DL, Cai XJ, et al. (2012). Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment. J Biomed Mater Res A 100A:2499–506
  • Trotta F, Zanetti M, Cavalli R. (2012). Cyclodextrin-based nanosponges as drug carriers. Beilstein J Org Chem 8:2091–9
  • Wu J, Wang YS, Yang XY, et al. (2012). Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology 23:355101 (1--9)
  • Yang GH, Cao JT, Li LL, et al. (2013). Carboxymethyl chitosan-functionalized graphene for label-free electrochemical cytosensing. Carbon 51:124–33
  • Yannakopoulou K. (2012). Cationic cyclodextrins: cell penetrating agents and other diverse applications. J Drug Deliv Sci Tech 22:243–9
  • Yhaya F, Binauld S, Kim Y, et al. (2012). Shell cross-linking of cyclodextrin-based micelles via supramolecular chemistry for the delivery of drugs. Macromol Rapid Comm 33:1868–74
  • Zhang LM, Xia JG, Zhao QH, et al. (2010). Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 6:537–44

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.